Christine Turner

Christine’s practice focuses on capital markets transactions. She represents investment banks and late-stage private and public companies in a variety of corporate and securities transactions, including initial public offerings (IPOs), follow-on and secondary offerings, private placements and convertible debt offerings.

Christine’s representative transactions include advising:

•  Structure Therapeutics in its $185.3 million IPO
• The underwriters in Arcutis Biotherapeutics’s $172.5 million follow-on offering
• The underwriters in Apellis Pharmaceuticals’s $402.5 million follow-on offering
• The underwriters in IGM Biosciences’s $230 million follow-on offering
• The underwriters in Doximity’s $697 million IPO
• The underwriters in FIGS’ $668 million IPO
• The underwriters in Treace Medical Concepts’ $220 million IPO
• ZoomInfo Technologies in its $1.07 billion IPO*

Christine’s representative private placements include advising:

• The placement agent in Vertex Energy’s $155 million offering of convertible senior notes
• The placement agent in Porch Group’s $333.3 million offering of convertible senior notes
• The placement agent in New Mountain Finance Corporation’s $200 million offering of convertible senior notes

* Representation handled prior to joining Cooley

Before joining Cooley, Christine was a capital markets associate in the New York office of Simpson Thacher & Bartlett. Christine also served as a law clerk to Vice Chancellor Sam Glasscock III on the Delaware Court of Chancery during the 2015 – 2016 term.

While in law school, Christine served as managing editor of the Duke Law Journal.